LIF and Cachexia: Consequently, mice bearing C26-LIF KO tumors had a much longer survival than C26 tumor-bearing mice; the majority of mice bearing C26-LIF KO tumors reached the humane endpoint due to tumor size, while only a small percentage of these mice reached the humane endpoint due to cachexia (Fig. S1D).